Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant
Saved in:
| Main Authors: | Karin Yaacoby-Bianu, Moshe Heching, Mordechai R. Kramer, Einat Shmueli, Dario Prais, François Vermeulen, Anabela S. Ramalho, Raya Cohen, Galit Livnat, Michal Shteinberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-01-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/11/1/00386-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medical clown intervention shortens length of hospitalization in children with pneumonia
by: Lana Khoury, et al.
Published: (2025-06-01) -
The CFTR K464N variant in fetuses potential increases premature birth risk in Chinese families
by: Jingping Li, et al.
Published: (2025-03-01) -
Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study
by: Evgeni Gershman, et al.
Published: (2020-09-01) -
P359: Genetic characteristic of Thai patients with primary craniosynostosis
by: Rungroj Thangpong, et al.
Published: (2025-01-01) -
Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects
by: Ana Lúcia Da Silva Cunha, et al.
Published: (2024-12-01)